Jarzebowski Witold, Caumes Eric, Dupin Nicolas, Farhi David, Lascaux Anne-Sophie, Piketty Christophe, de Truchis Pierre, Bouldouyre Marie-Anne, Derradji Ouda, Pacanowski Jérome, Costagliola Dominique, Grabar Sophie
Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Unité de Biostatistique et Epidémiologie, Paris, France.
Arch Intern Med. 2012 Sep 10;172(16):1237-43. doi: 10.1001/archinternmed.2012.2706.
Concomitant syphilis and human immunodeficiency virus (HIV) infection is increasingly frequent in industrialized countries.
From a large hospital cohort of HIV-infected patients followed up in the Paris area between 1998 and 2006, we examined the effect of early syphilis on plasma HIV-1 RNA levels and CD4 cell counts. We compared 282 HIV-1-infected men diagnosed as having incident primary or secondary syphilis with 1233 syphilis-free men matched for age (±5 years), sexual orientation, participating center, length of follow-up (±6 months), and immunologic and virologic status before the date of syphilis diagnosis (index date). Increase in viral load (VL) (plasma HIV-1 RNA) of at least 0.5 log or a rise to greater than 500 copies/mL in patients with previously controlled VL during the 6 months after the index date was analyzed, as were CD4 cell count variations and CD4 slope after the index date.
During the 6 months after the index date, VL increase was observed in 77 men with syphilis (27.3%) and in 205 syphilis-free men (16.6%) (adjusted odds ratio [aOR], 1.87; 95% CI, 1.40-2.49). Even in men with a VL of less than 500 copies/mL undergoing antiretroviral therapy, syphilis was associated with a higher risk of VL increase (aOR, 1.52; 95% CI, 1.02-2.26). The CD4 cell count decreased significantly (mean, -28/μL) compared with the syphilis-free group during the syphilis episode (P = .001) but returned to previous levels thereafter.
In HIV-infected men, syphilis was associated with a slight and transient decrease in the CD4 cell count and with an increase in VL, which implies that syphilis may increase the risk of HIV transmission, even in patients receiving antiretroviral therapy and with a VL of less than 500 copies/mL.
在工业化国家,梅毒与人类免疫缺陷病毒(HIV)合并感染日益常见。
从1998年至2006年在巴黎地区随访的一大群HIV感染患者中,我们研究了早期梅毒对血浆HIV-1 RNA水平和CD4细胞计数的影响。我们将282例被诊断为初发或二期梅毒的HIV-1感染男性与1233例无梅毒男性进行比较,这些无梅毒男性在年龄(±5岁)、性取向、参与研究的中心、随访时间(±6个月)以及梅毒诊断日期(索引日期)之前的免疫和病毒学状态方面相匹配。分析了索引日期后6个月内病毒载量(VL)(血浆HIV-1 RNA)至少增加0.5 log或之前VL得到控制的患者中VL升至大于500拷贝/mL的情况,以及索引日期后的CD4细胞计数变化和CD4斜率。
在索引日期后的6个月内,77例梅毒患者(27.3%)出现VL升高,205例无梅毒患者(16.6%)出现VL升高(校正比值比[aOR],1.87;95%可信区间[CI],1.40 - 2.49)。即使在接受抗逆转录病毒治疗且VL低于500拷贝/mL的男性中,梅毒也与VL升高风险较高相关(aOR,1.52;95% CI,1.02 - 2.26)。与无梅毒组相比,梅毒发作期间CD4细胞计数显著下降(平均,-28/μL)(P = .001),但之后恢复到先前水平。
在HIV感染男性中,梅毒与CD4细胞计数轻微且短暂下降以及VL升高相关,这意味着即使在接受抗逆转录病毒治疗且VL低于500拷贝/mL的患者中,梅毒也可能增加HIV传播风险。